Tag: Dr Reddy’s
Dr Reddy’s gets DCGI nod for Phase 3 clinical trial for...
Dr Reddy’s Laboratories has received approval from the Drugs Control General of India (DCGI) to conduct phase 3 clinical trial for the...
India to produce 300 million Sputnik V vaccines
India will produce about 300 million doses of Russia’s Sputnik V C-19 virus vaccines next year, a Russian official was quoted as...
Dr Reddy’s inks licensing pact with Gilead for Remdesivir
Hyderabad: Indian generic drug maker Dr Reddy’s Laboratories announced entering into a non-exclusive licensing agreement with Gilead Sciences, which grants the Indian firm...
Dr. Reddy’s receives EIR from USFDA
Dr. Reddy's receives EIR from USFDA
Dr Reddy's Laboratories Ltd has received the Establishment Inspection Report (EIR) from US...
Dr Reddy’s recalls its heart burn medicine
Dr Reddy’s recalls its heart burn medicine in US
Dr Reddy’s Laboratories is recalling 1,752 bottles of generic heartburn...
USFDA seeks voluntary action at Dr Reddy’s
New Delhi: The US health regulator has asked drug major Dr Reddy's Laboratories to initiate voluntary action at its Duvvada facility in Andhra Pradesh.
Dr. Reddy’s launches generic Syprine capsules
Dr. Reddy's Laboratories Ltd announced the launch of the US Food and Drug Administration (FDA) approved trientine hydrochloride capsules USP, 250 mg,...
Latest posts
Medicine: अब कम समय में असर करेगी दवाएं, इजाद हुआ नया...
Medicine: अब कम समय में असर करेगी दवाएं, इजाद हुआ नया Formula
लखनऊ । इमरजेंसी और ट्रॉमा के मामले में...
Authors
